Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 8, 2009 - Issue 3
Submit an article Journal homepage
561
Views
24
CrossRef citations to date
0
Altmetric
Reviews

Suicidality and montelukast

Partam Manalai Mood and Anxiety Program (MAP), University of Maryland School of Medicine, Department of Psychiatry, 685 West Baltimore Street, MSTF Building Room 930, Baltimore, MD 21201, USA +1 410 706 2323; +1 410 706 0751; [email protected]; Saint Elizabeth Hospital Psychiatry Residency Training Program, Department of Mental Health, Washington DC, USA
,
Jong-Min Woo Mood and Anxiety Program (MAP), University of Maryland School of Medicine, Department of Psychiatry, 685 West Baltimore Street, MSTF Building Room 930, Baltimore, MD 21201, USA +1 410 706 2323; +1 410 706 0751; [email protected]; Inje University School of Medicine, Seoul Paik Hospital, Department of Psychiatry, Seoul, Korea; Inje University, Stress Research Institute, Seoul, Korea
&
Teodor T Postolache Mood and Anxiety Program (MAP), University of Maryland School of Medicine, Department of Psychiatry, 685 West Baltimore Street, MSTF Building Room 930, Baltimore, MD 21201, USA +1 410 706 2323; +1 410 706 0751; [email protected]; Saint Elizabeth Hospital Psychiatry Residency Training Program, Department of Mental Health, Washington DC, USA; National Center for the Treatment of Phobias, Anxiety and Depression, Washington DC, USA
, MD
Pages 273-282 | Published online: 12 May 2009

Citations (24)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Esther H. Zhou, Sigal Kaplan, Andrew Mosholder, David Moeny, Yulan Ding, Yute Wu, Solomon Iyasu & Tarek A. Hammad. (2013) Antidepressant medication dispensing among montelukast initiators. Journal of Asthma 50:9, pages 990-995.
Read now
Salima Amlani, Thanu Nadarajah & Richard Andrew McIvor. (2011) Montelukast for the treatment of asthma in the adult population. Expert Opinion on Pharmacotherapy 12:13, pages 2119-2128.
Read now
Salima Amlani & R Andrew McIvor. (2011) Montelukast in childhood asthma: what is the evidence for its use?. Expert Review of Respiratory Medicine 5:1, pages 17-25.
Read now

Articles from other publishers (21)

Jung-Hyun Kim, Hyesung Lee, Dongyeon Jeong, Ji-Hyang Lee, Hyouk-Soo Kwon, Woo-Jung Song, You Sook Cho, Ye-Jee Kim, Yong-Wook Shin & Tae-Bum Kim. (2023) The Risk of Neuropsychiatric Adverse Events With Use of Leukotriene Receptor Antagonists in Patients With Asthma: Analysis of Korea’s National Health Insurance Sharing Service Database. The Journal of Allergy and Clinical Immunology: In Practice 11:12, pages 3690-3699.e7.
Crossref
Pengbo Gao & Chenyi Zhou. (2023) Progress of three kinds of treatment for asthma. Highlights in Science, Engineering and Technology 54, pages 225-232.
Crossref
Cátia F. Marques, Maria Matilde Marques & Gonçalo C. Justino. (2022) Leukotrienes vs. Montelukast—Activity, Metabolism, and Toxicity Hints for Repurposing. Pharmaceuticals 15:9, pages 1039.
Crossref
Paul Grama, Corina Ureche, Corina-Adelina Zah & Corina Bocșan. (2020) Neuropsychiatric side effects induced by montelukast. Alergologia 3:4, pages 137.
Crossref
S A Stuart, C M Wood & E S J Robinson. (2017) Using the affective bias test to predict drug-induced negative affect: implications for drug safety. British Journal of Pharmacology 174:19, pages 3200-3210.
Crossref
T D Gould, P Georgiou, L A Brenner, L Brundin, A Can, P Courtet, Z R Donaldson, Y Dwivedi, S Guillaume, I I Gottesman, S Kanekar, C A Lowry, P F Renshaw, D Rujescu, E G Smith, G Turecki, P Zanos, C A ZarateJrJr, P A Zunszain & T T Postolache. (2017) Animal models to improve our understanding and treatment of suicidal behavior. Translational Psychiatry 7:4, pages e1092-e1092.
Crossref
Andrew G. Ayars & Matthew C. Altman. (2016) Pharmacologic Therapies in Pulmonology and Allergy. Medical Clinics of North America 100:4, pages 851-868.
Crossref
Ana Aldea Perona, Mar García-Sáiz & Emilio Sanz Álvarez. (2015) Psychiatric Disorders and Montelukast in Children: A Disproportionality Analysis of the VigiBase®. Drug Safety 39:1, pages 69-78.
Crossref
Tsutomu Tamada & Masakazu Ichinose. 2017. Pharmacology and Therapeutics of Asthma and COPD. Pharmacology and Therapeutics of Asthma and COPD 153 169 .
Jessa KochSarah WardBobbie MartinChristopher Thomas. (2015) A review of suicidality in nonpsychotropic medications. Mental Health Clinician 5:5, pages 224-236.
Crossref
Gioacchino Calapai, Marco Casciaro, Marco Miroddi, Fabrizio Calapai, Michele Navarra & Sebastiano Gangemi. (2014) Montelukast-Induced Adverse Drug Reactions: A Review of Case Reports in the Literature. Pharmacology 94:1-2, pages 60-70.
Crossref
Letty A. de Weger, Karl Christian Bergmann, Auli Rantio-Lehtimäki, Åslög Dahl, Jeroen Buters, Chantal Déchamp, Jordina Belmonte, Michel Thibaudon, Lorenzo Cecchi, Jean-Pierre Besancenot, Carmen Galán & Yoav Waisel. 2013. Allergenic Pollen. Allergenic Pollen 161 215 .
Glen T. Schumock, Robert D. Gibbons, Todd A. Lee, Min J. Joo, Leslie T. Stayner & Robert J. Valuck. (2012) The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide. Drug Information Journal 46:1, pages 99-106.
Crossref
Maria Bygdell, Gertrud Brunlöf, Susanna M. Wallerstedt & Jenny M. Kindblom. (2012) Psychiatric adverse drug reactions reported during a 10-year period in the Swedish pediatric population. Pharmacoepidemiology and Drug Safety 21:1, pages 79-86.
Crossref
Sanjay N. Mandhane, Jigar H. Shah & Rajamannar Thennati. (2011) Allergic rhinitis: An update on disease, present treatments and future prospects. International Immunopharmacology 11:11, pages 1646-1662.
Crossref
Glen T. Schumock, Todd A. Lee, Min J. Joo, Robert J. Valuck, Leslie T. Stayner & Robert D. Gibbons. (2011) Association between Leukotriene-Modifying Agents and Suicide. Drug Safety 34:7, pages 533-544.
Crossref
Sang-Bin BaeJong-Min Woo. (2011) Suicide prevention strategies from medical perspective. Journal of the Korean Medical Association 54:4, pages 386.
Crossref
Mohsen NasirJ. Andrew Grant. (2011) Update on Clinical Options for the Management of Allergic Rhinitis. Clinical Medicine Insights: Therapeutics 3, pages CMT.S6375.
Crossref
Paolo Montuschi. (2010) Role of Leukotrienes and Leukotriene Modifiers in Asthma. Pharmaceuticals 3:6, pages 1792-1811.
Crossref
George Philip, Carolyn Hustad, Gertrude Noonan, Marie-Pierre Malice, Alan Ezekowitz, Theodore F. Reiss & Barbara Knorr. (2009) Reports of suicidality in clinical trials of montelukast. Journal of Allergy and Clinical Immunology 124:4, pages 691-696.e6.
Crossref
Michael S. BenningerHeather Waters. (2009) Montelukast: Pharmacology, Safety, Tolerability and Efficacy. Clinical Medicine. Therapeutics 1, pages CMT.S1147.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.